14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
DXCM vs SNN: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, DexCom, Inc. (DXCM) is the stronger overall head-to-head candidate over Smith & Nephew plc (SNN) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). DXCM carries a Unified Composite Score of 50.8/100 (HOLD) at $79.32 (25.3x Forward P/E, 24.0% operating margin), whereas SNN carries 36.9/100 (SELL) at $29.83 (12.6x Forward P/E, 14.2% operating margin).
Technical & Structure Timing Caution: DXCM is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 43.0); meanwhile SNN trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 46.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DXCM vs SNN. Trailing 12-month operating profitability (DXCM 24.0% vs SNN 14.2%) and valuation multiples (DXCM 25.3x vs SNN 12.6x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Medical Devices value chain with $12.5B market capitalization and 14.2% operating margin.
OpEx & R&D Reinvestment54.2% of Rev ($3.41B)
90D Engineering Disclosures0 Published
Investor FAQ DXCM vs SNN Key Questions & Quantitative Answers
As of Nov 20, 2026, DexCom, Inc. (DXCM) is the stronger overall head-to-head candidate over Smith & Nephew plc (SNN) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). DXCM carries a Unified Composite Score of 50.8/100 (HOLD) at $79.32 (25.3x Forward P/E, 24.0% operating margin), whereas SNN carries 36.9/100 (SELL) at $29.83 (12.6x Forward P/E, 14.2% operating margin). Technical & Structure Timing Caution: DXCM is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 43.0); meanwhile SNN trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 46.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
DXCM leads the Growth & Scale pillar: DXCM posts +11.2% YoY revenue growth and +2.6% YoY earnings growth on $5.10B TTM revenue (63.4% gross margin, 24.0% operating margin), compared with SNN at +4.6% YoY revenue growth and +5.7% YoY earnings growth on $6.30B TTM revenue (68.4% gross margin, 14.2% operating margin). On trailing 12-month operating scale, DXCM generates $5.10B in USD-normalized revenue versus $6.30B for SNN. In operating R&D and SG&A reinvestment, DXCM deploys 39.4% of Rev ($2.01B) (0 90-day corporate R&D disclosures) versus 54.2% of Rev ($3.41B) (0 disclosures) for SNN.
SNN screens cheaper on headline valuation multiples. DXCM trades at 25.3x Forward P/E, 31.6x Trailing P/E, 1.30x PEG, and 5.9x EV/Revenue (33.9% FCF margin), whereas SNN trades at 12.6x Forward P/E, 20.3x Trailing P/E, 1.11x PEG, and 2.0x EV/Revenue (21.9% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against DXCM (37.7% ROE) versus SNN (11.8% ROE) capital efficiency.
In options market volatility and institutional positioning, DXCM carries 63.0% implied volatility (15th %ile, Compressed (<25th %ile)), a 0.48x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.59β · 43% Vol realized risk). By comparison, SNN carries 19.6% implied volatility (50th %ile, Balanced (25th–60th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.27β · 32% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.